A New Study on Brain Injuries
June 05, 2016
Thorne Research, a global healthcare company dedicated to improving the health and wellness of people through science and technology, announced a new clinical study to assess the effect of Nicotinamide Riboside (NR) on brain NAD+ in college football players.
The study is scheduled to begin in May 2016 in collaboration with The Mayo Clinic and University of Minnesota Clinical and Translational Science Institute. We’ll continue to provide updates on the study but in the meantime, you can learn more here.